Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer

Patrick Ross, John Grecula, Tanios Bekaii-Saab, Miguel Villalona-Calero, Gregory Otterson, Cynthia Magro

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background and Objectives: Incorporation of photodynamic therapy (PDT) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (NSCLC) is explored. Study Design/Materials and Methods: We present a retrospective review of 41 patients diagnosed with non-metastatic NSCLC who underwent induction PDT with chemotherapy and/or radiation. Results: Fifty percent of patients initially deemed unresectable, were able to undergo definitive surgical resection after trimodality induction therapy. Twenty-seven percent of patients considered to require pneumonectomy were able to have a lobectomy. The pathological stage was less than the preinduction clinical stage in 14 of 22 cases; of which four patients had no residual tumor. There was no 30/90-day postoperative mortality. Mean survival was 35.9 months (lobectomy), 25.5 months (pneumonectomy) and 14.7 months (no surgery). Median survival was 78% (12 months) and 46% (36 months). The main postoperative complication following pneumonectomy was bronchopleural fistula formation. All patients who developed this complication had undergone trimodality induction therapy. Incorporation of PDT into the induction arsenal for patients with loco-regionally advanced NSCLC may be safely performed. Conclusions: PDT may define an alternative induction strategy for patients requiring pneumonectomy; further studies exploring the true efficacy of PDT as an induction modality are encouraged.

Original languageEnglish (US)
Pages (from-to)881-889
Number of pages9
JournalLasers in Surgery and Medicine
Volume38
Issue number10
DOIs
StatePublished - Dec 1 2006
Externally publishedYes

Fingerprint

Photochemotherapy
Non-Small Cell Lung Carcinoma
Pneumonectomy
Bronchogenic Carcinoma
Survival
Residual Neoplasm
Therapeutics
Fistula
Radiation
Drug Therapy
Mortality

Keywords

  • Bronchus
  • Diagnosis
  • Lung cancer
  • Staging and treatment

ASJC Scopus subject areas

  • Surgery

Cite this

Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. / Ross, Patrick; Grecula, John; Bekaii-Saab, Tanios; Villalona-Calero, Miguel; Otterson, Gregory; Magro, Cynthia.

In: Lasers in Surgery and Medicine, Vol. 38, No. 10, 01.12.2006, p. 881-889.

Research output: Contribution to journalArticle

Ross, Patrick ; Grecula, John ; Bekaii-Saab, Tanios ; Villalona-Calero, Miguel ; Otterson, Gregory ; Magro, Cynthia. / Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. In: Lasers in Surgery and Medicine. 2006 ; Vol. 38, No. 10. pp. 881-889.
@article{433f603c653b4b10940c440203dbbbd3,
title = "Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer",
abstract = "Background and Objectives: Incorporation of photodynamic therapy (PDT) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (NSCLC) is explored. Study Design/Materials and Methods: We present a retrospective review of 41 patients diagnosed with non-metastatic NSCLC who underwent induction PDT with chemotherapy and/or radiation. Results: Fifty percent of patients initially deemed unresectable, were able to undergo definitive surgical resection after trimodality induction therapy. Twenty-seven percent of patients considered to require pneumonectomy were able to have a lobectomy. The pathological stage was less than the preinduction clinical stage in 14 of 22 cases; of which four patients had no residual tumor. There was no 30/90-day postoperative mortality. Mean survival was 35.9 months (lobectomy), 25.5 months (pneumonectomy) and 14.7 months (no surgery). Median survival was 78{\%} (12 months) and 46{\%} (36 months). The main postoperative complication following pneumonectomy was bronchopleural fistula formation. All patients who developed this complication had undergone trimodality induction therapy. Incorporation of PDT into the induction arsenal for patients with loco-regionally advanced NSCLC may be safely performed. Conclusions: PDT may define an alternative induction strategy for patients requiring pneumonectomy; further studies exploring the true efficacy of PDT as an induction modality are encouraged.",
keywords = "Bronchus, Diagnosis, Lung cancer, Staging and treatment",
author = "Patrick Ross and John Grecula and Tanios Bekaii-Saab and Miguel Villalona-Calero and Gregory Otterson and Cynthia Magro",
year = "2006",
month = "12",
day = "1",
doi = "10.1002/lsm.20444",
language = "English (US)",
volume = "38",
pages = "881--889",
journal = "Lasers in Surgery and Medicine",
issn = "0196-8092",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer

AU - Ross, Patrick

AU - Grecula, John

AU - Bekaii-Saab, Tanios

AU - Villalona-Calero, Miguel

AU - Otterson, Gregory

AU - Magro, Cynthia

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Background and Objectives: Incorporation of photodynamic therapy (PDT) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (NSCLC) is explored. Study Design/Materials and Methods: We present a retrospective review of 41 patients diagnosed with non-metastatic NSCLC who underwent induction PDT with chemotherapy and/or radiation. Results: Fifty percent of patients initially deemed unresectable, were able to undergo definitive surgical resection after trimodality induction therapy. Twenty-seven percent of patients considered to require pneumonectomy were able to have a lobectomy. The pathological stage was less than the preinduction clinical stage in 14 of 22 cases; of which four patients had no residual tumor. There was no 30/90-day postoperative mortality. Mean survival was 35.9 months (lobectomy), 25.5 months (pneumonectomy) and 14.7 months (no surgery). Median survival was 78% (12 months) and 46% (36 months). The main postoperative complication following pneumonectomy was bronchopleural fistula formation. All patients who developed this complication had undergone trimodality induction therapy. Incorporation of PDT into the induction arsenal for patients with loco-regionally advanced NSCLC may be safely performed. Conclusions: PDT may define an alternative induction strategy for patients requiring pneumonectomy; further studies exploring the true efficacy of PDT as an induction modality are encouraged.

AB - Background and Objectives: Incorporation of photodynamic therapy (PDT) into the induction therapy regimen utilized for treatment of locally advanced primary non-small cell bronchogenic carcinoma (NSCLC) is explored. Study Design/Materials and Methods: We present a retrospective review of 41 patients diagnosed with non-metastatic NSCLC who underwent induction PDT with chemotherapy and/or radiation. Results: Fifty percent of patients initially deemed unresectable, were able to undergo definitive surgical resection after trimodality induction therapy. Twenty-seven percent of patients considered to require pneumonectomy were able to have a lobectomy. The pathological stage was less than the preinduction clinical stage in 14 of 22 cases; of which four patients had no residual tumor. There was no 30/90-day postoperative mortality. Mean survival was 35.9 months (lobectomy), 25.5 months (pneumonectomy) and 14.7 months (no surgery). Median survival was 78% (12 months) and 46% (36 months). The main postoperative complication following pneumonectomy was bronchopleural fistula formation. All patients who developed this complication had undergone trimodality induction therapy. Incorporation of PDT into the induction arsenal for patients with loco-regionally advanced NSCLC may be safely performed. Conclusions: PDT may define an alternative induction strategy for patients requiring pneumonectomy; further studies exploring the true efficacy of PDT as an induction modality are encouraged.

KW - Bronchus

KW - Diagnosis

KW - Lung cancer

KW - Staging and treatment

UR - http://www.scopus.com/inward/record.url?scp=33845935537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845935537&partnerID=8YFLogxK

U2 - 10.1002/lsm.20444

DO - 10.1002/lsm.20444

M3 - Article

C2 - 17115382

AN - SCOPUS:33845935537

VL - 38

SP - 881

EP - 889

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 10

ER -